A pragmatic clinical trial of cascade testing for familial hypercholesterolemia
- 29 September 2022
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 24 (12) , 2535-2543
Abstract
No abstract availableKeywords
Funding Information
- National Human Genome Research Institute (U01HG006379-S)
- National Heart, Lung, and Blood Institute (HL137010)
- National Heart, Lung, and Blood Institute (HL135879)
- National Heart, Lung, and Blood Institute (NCT03640234)
This publication has 41 references indexed in Scilit:
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe HypercholesterolemiaJACC, 2016
- The Agenda for Familial HypercholesterolemiaCirculation, 2015
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2Journal of Clinical Lipidology, 2015
- Genomics in Public Health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC)Healthcare, 2015
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control studyThe Lancet, 2013
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary ReportPediatrics, 2011
- Familial hypercholesterolaemia: summary of NICE guidanceBMJ, 2008
- Cascade testing in familial hypercholesterolaemia: how should family members be contacted?European Journal of Human Genetics, 2005
- Advanced Method for the Identification of Patients with Inherited HypercholesterolemiaSeminars in Vascular Medicine, 2004